NYAS Conferences
New York Academy of Sciences
left end
Search
divider divider feedback right end
Annals of the New York Academy of Sciences Annals of the New York Academy of Sciences login

Main

Browse Volumes

Forthcoming Volumes

Annals PrePrints

Annals Extra

E-mail Alerts

Subscriptions & Orders

New Proposals

Author Guidelines

About Annals

Help

Get free Annals volume as a NYAS member: http://www.nyas.org/annalsreaderhw
Issue 1032 coverBiobehavioral Stress Response: Protective and Damaging Effects Volume 1032 published December 2004
Ann. N.Y. Acad. Sci. 1032: 158–166 (2004). doi: 10.1196/annals.1314.013
Copyright © 2004 by the New York Academy of Sciences
description | purchase volume purchase this volume

This Volume
Table of Contents
Description
This Article
Full Text
Full Text (PDF)
Services
Similar articles in this journal
Similar articles in PubMed
Alert me to new issues of the journal
Download to citation manager
Citing Articles
Citing Articles via HighWire
Citing Articles via Google Scholar
Google Scholar
Articles by SCHELLING, G.
Articles by DE QUERVAIN, D. J.-F.
Search for Related Content
PubMed
PubMed Citation
Articles by SCHELLING, G.
Articles by DE QUERVAIN, D. J.-F.
Can Posttraumatic Stress Disorder Be Prevented with Glucocorticoids?

GUSTAV SCHELLING, BENNO ROOZENDAAL AND DOMINIQUE J.-F. DE QUERVAIN

Department of Anaesthesiology, Ludwig-Maximilians-University, Munich, Germany

Address for correspondence: G. Schelling, MD, PhD, Ludwig-Maximilians University, Klinikum Grosshadern, Department of Anaesthesiology, 81377 Muenchen, Germany. Voice: +49897095-1 (operator); fax: +498970958886. gustav.schelling{at}med.uni-muenchen.de

Patients with critical illness who are treated in an intensive care unit (ICU) often report traumatic memories from ICU treatment, receive exogenously administered glucocorticoids for medical reasons, and have a relatively high incidence of chronic stress symptoms and posttraumatic stress disorder (PTSD) during follow-up. ICU therapy could therefore represent a useful model for investigating glucocorticoid effects on traumatic memories and PTSD development. Studies in long-term survivors of ICU treatment demonstrated a clear and vivid recall of different categories of traumatic memory such as nightmares, anxiety, respiratory distress, or pain. The incidence and intensity of PTSD symptoms increased with the number of categories of traumatic memory present. The prolonged administration of glucocorticoids (stress doses of hydrocortisone) to critically ill patients resulted in a significant reduction of PTSD symptoms measured after recovery without influencing the number of categories of traumatic memory. This protective effect of cortisol can possibly be explained by a cortisol-induced temporary impairment in traumatic memory retrieval which has previously been demonstrated in both rats and humans. Therefore, stress doses of hydrocortisone could be useful for prophylaxis and treatment of PTSD.

Key Words: PTSD • glucocorticoids • hydrocortisone • traumatic memory • stress • intensive care unit • cortisol




This article has been cited by other articles:


Home page
J Am Acad Psychiatry LawHome page
D. Bourget and L. Whitehurst
Amnesia and Crime
J Am Acad Psychiatry Law, December 1, 2007; 35(4): 469 - 480.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
B. S. McEwen
Physiology and Neurobiology of Stress and Adaptation: Central Role of the Brain
Physiol Rev, July 1, 2007; 87(3): 873 - 904.
[Abstract] [Full Text] [PDF]


Home page
Behav ModifHome page
M. T. Feldner, C. M. Monson, and M. J. Friedman
A Critical Analysis of Approaches to Targeted PTSD Prevention: Current Status and Theoretically Derived Future Directions
Behav Modif, January 1, 2007; 31(1): 80 - 116.
[Abstract] [PDF]


Home page
J. Neurosci.Home page
W.-H. Cai, J. Blundell, J. Han, R. W. Greene, and C. M. Powell
Postreactivation glucocorticoids impair recall of established fear memory.
J. Neurosci., September 13, 2006; 26(37): 9560 - 9566.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
R. YEHUDA
Advances in Understanding Neuroendocrine Alterations in PTSD and Their Therapeutic Implications
Ann. N.Y. Acad. Sci., July 1, 2006; 1071(1): 137 - 166.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
R. BRUNNER, D. SCHAEFER, K. HESS, P. PARZER, F. RESCH, and S. SCHWAB
Effect of High-Dose Cortisol on Memory Functions
Ann. N.Y. Acad. Sci., July 1, 2006; 1071(1): 434 - 437.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
F. Weis, E. Kilger, B. Roozendaal, D. J.-F. de Quervain, P. Lamm, M. Schmidt, M. Schmolz, J. Briegel, and G. Schelling
Stress doses of hydrocortisone reduce chronic stress symptoms and improve health-related quality of life in high-risk patients after cardiac surgery: A randomized study
J. Thorac. Cardiovasc. Surg., February 1, 2006; 131(2): 277 - 282.
[Abstract] [Full Text] [PDF]


Home page
Ann. N. Y. Acad. Sci.Home page
S. E. SCHUDER
Stress-Induced Hypocortisolemia Diagnosed as Psychiatric Disorders Responsive to Hydrocortisone Replacement
Ann. N.Y. Acad. Sci., December 1, 2005; 1057(1): 466 - 478.
[Abstract] [Full Text] [PDF]



footerLeft footerRight